glp 1 insurance changes Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss ATTENTION ALL STATE HEALTH BENEFIT
Description
Introduction and Background GLP-1 receptor agonists have revolutionized diabetes and obesity care with dramatic efficacy
04 Skin Preservation Rapid GLP-1-induced fat loss can cause "Ozempic face", visible facial-volume depletion

doi: 10.3803/EnM.2024.2164

a puncture-resistant container for used needles and pens (see "Throwing your pen away")

Cagrilintide as a standalone drug does not appear to be pursuing separate FDA approval at this time, as Novo Nordisk is focusing on the combination product
